These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 7529381)
1. In-vitro effects of cyclosporin A, FK506, 6-mercaptopurine, and prednisolone on lymphokine-activated killer cells. Alamartine E; Sabido O; Berthoux F Nephrol Dial Transplant; 1994; 9(10):1456-61. PubMed ID: 7529381 [TBL] [Abstract][Full Text] [Related]
2. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients. Provinciali M; Di Stefano G; Stronati S; Fabris N Cytokine; 1998 Feb; 10(2):132-9. PubMed ID: 9512903 [TBL] [Abstract][Full Text] [Related]
3. [Cytolytic activity by lymphokines (LAK activity) in chronic myeloid leukemia]. Cervantes F; Miller JS; McGlave PB Med Clin (Barc); 1995 Jun; 105(2):50-3. PubMed ID: 7603094 [TBL] [Abstract][Full Text] [Related]
4. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function. Lin SJ; Kuo ML Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772 [TBL] [Abstract][Full Text] [Related]
5. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Vujanovic NL; Rabinowich H; Lee YJ; Jost L; Herberman RB; Whiteside TL Cell Immunol; 1993 Oct; 151(1):133-57. PubMed ID: 8402925 [TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor. Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro. Shields LE; Sieverkropp AJ; Potter J; Andrews RG Am J Primatol; 2006 Aug; 68(8):753-64. PubMed ID: 16847969 [TBL] [Abstract][Full Text] [Related]
8. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering. Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934 [TBL] [Abstract][Full Text] [Related]
9. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study. Jorgensen H; Hokland P; Jensen T; Basse P; Hokland M Nat Immun; 1995; 14(3):164-72. PubMed ID: 8832900 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in lectin-binding characteristics of human lymphokine-activated killer cells. Maruyama T; Imai Y; Harada K; Okada T; Takano M; Ikeda Y; Toda G; Oka H; Osawa T J Biol Response Mod; 1990 Aug; 9(4):378-86. PubMed ID: 2395003 [TBL] [Abstract][Full Text] [Related]
12. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells]. Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543 [TBL] [Abstract][Full Text] [Related]
13. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
15. The correlation between the percent of CD3- CD56+ cells and NK precursor function. Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569 [TBL] [Abstract][Full Text] [Related]
16. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity. Spagnoli GC; Juretic A; Schultz-Thater E; Dellabona P; Filgueira L; Hörig H; Zuber M; Garotta G; Heberer M Cell Immunol; 1993 Feb; 146(2):391-405. PubMed ID: 8174177 [TBL] [Abstract][Full Text] [Related]
17. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related]
18. Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cells. Koberda J; Przepiorka D; Moser RP; Grimm EE Lymphokine Cytokine Res; 1994 Apr; 13(2):139-45. PubMed ID: 8061115 [TBL] [Abstract][Full Text] [Related]
19. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells. Atzpodien J; Gulati SC Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310 [TBL] [Abstract][Full Text] [Related]
20. The effect of light, moderate and severe bicycle exercise on lymphocyte subsets, natural and lymphokine activated killer cells, lymphocyte proliferative response and interleukin 2 production. Tvede N; Kappel M; Halkjaer-Kristensen J; Galbo H; Pedersen BK Int J Sports Med; 1993 Jul; 14(5):275-82. PubMed ID: 8365836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]